Trending
- Novel Agent Begins STARLIGHT-1 Dose Expansion in Relapsed/Refractory B-Cell NHL
- Consolidative Radiotherapy Adds Toxicity Without Survival Benefit in SCLC
- RON receptor tyrosine kinase regulates abiraterone resistance in prostate cancer via the methylation-dependent and independent dual functions of DNMT1
- Managing Ipilimumab Dosing and Immune-Related Toxicity in Frontline HCC
- Relapsed/Refractory Multiple Myeloma: Future Directions for T-Cell–Redirecting Therapies
- Integration of hierarchical clustering in hematologic biomarkers prediction for endocrine toxicity during immunotherapy in lung cancer patients
- Krüppel-like factor 4 downregulation during esophageal cancer formation facilitates immune evasion and impairs immunotherapy
- Adipose triglyceride lipase driven lipolysis as a targetable metabolic vulnerability in prostate cancer with intrinsic metabolic inflexibility
Friday, July 24